Evidence map›Paper›PMID 28783042›Full record

ArticleThe Journal of clinical investigation2017

Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections.

Benson Ogunjimi, Shen-Ying Zhang, Katrine B Sørensen, Kristian A Skipper, Madalina Carter-Timofte, Gaspard Kerner, Stefanie Luecke, Thaneas Prabakaran, Yujia Cai, Josephina Meester and 35 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Varicella zoster virus and the central nervous system.Nature reviews. Microbiology · 2026
    Review
  5. Review
  6. Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Review
  9. Biological relevance ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 17 institutions in 6 countries.

Benson OgunjimiCentre for Health Economics Research & Modeling Infectious Diseases, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Shen-Ying ZhangSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
Katrine B SørensenDepartment of Infectious Diseases, Aarhus University Hospital Skejby, Aarhus, Denmark.
Kristian A SkipperDepartment of Biomedicine and.
Madalina Carter-TimofteDepartment of Infectious Diseases, Aarhus University Hospital Skejby, Aarhus, Denmark.
Gaspard KernerLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Paris, France.
Stefanie LueckeDepartment of Biomedicine and.
Thaneas PrabakaranDepartment of Biomedicine and.
Yujia CaiDepartment of Biomedicine and.
Josephina MeesterCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Esther BartholomeusCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Nikhita Ajit BolarCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Geert VandeweyerCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Charlotte ClaesCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Yasmine SillisCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Lazaro LorenzoSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
Raffaele A FiorenzaSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
Soraya BoucheritSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
Charlotte DielmanDepartment of Child Neurology, Queen Paola Child Hospital, Antwerp, Belgium.
Steven HeynderickxLaboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
George EliasLaboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Andrea KurotovaDepartment of Pediatrics, Sint-Vincentius Hospital, Antwerp, Belgium.
Ann Vander AuweraDepartment of Pediatrics, Sint-Augustinus Hospital, Antwerp, Belgium.
Lieve VerstraeteChild Neurology, Heilig Hart Hospital Lier, Lier, Belgium.
Lieven LagaeDepartment of Development and Regeneration - Section Paediatric Neurology, University Hospitals KULeuven, Leuven, Belgium.
Helene VerhelstDepartment of Paediatric Neurology, Ghent University Hospital, Ghent, Belgium.
Anna JansenPediatric Neurology Unit, Department of Pediatrics, UZ Brussel, Brussels, Belgium.
Jose RametDepartment of Pediatrics, Antwerp University Hospital, Antwerp, Belgium.
Arvid SulsCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Evelien SmitsLaboratory of Experimental Hematology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Berten CeulemansDepartment of Neurology, Pediatric Neurology, Antwerp University Hospital & University of Antwerp, Antwerp, Belgium.
Lut Van LaerCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Genevieve Plat WilsonCHU Toulouse - Children's Hospital, Pediatric Onco-Hematology, Toulouse, France.
Jonas KrethNeuropediatric Department, Hospital for Children and Adolescents, gGmbH Klinikum Leverkusen, Leverkusen, Germany.
Capucine PicardLaboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Paris, France.
Horst Von BernuthDepartment of Pediatric Pulmonology and Immunology, Charité Berlin - Campus Rudolf Virchow, Berlin, Germany.
Joël FlussFMH Pediatric Neurology, Children's Hospital, Geneva, Switzerland.
Stephane ChabrierCHU Saint-Étienne, French Centre for Paediatric Stroke, Saint-Étienne, France.
Laurent AbelSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
Geert MortierCenter of Medical Genetics, University of Antwerp & Antwerp University Hospital, Antwerp, Belgium.
Sebastien FribourgUnversité Bordeaux, INSERM U1212 CNRS 5320, Bordeaux, France.
Jacob Giehm MikkelsenDepartment of Biomedicine and.
Jean-Laurent CasanovaSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York, USA.
Søren R PaludanDepartment of Biomedicine and.
Trine H MogensenDepartment of Infectious Diseases, Aarhus University Hospital Skejby, Aarhus, Denmark.
University of Antwerp · BEAarhus University · DKInserm · FRAntwerp University Hospital · BEAZ Sint-Blasius · BECentre Hospitalier Universitaire de Saint-Étienne · FRCentre Hospitalier Universitaire de Toulouse · FRCentre National de la Recherche Scientifique · FRCharité - Universitätsmedizin Berlin · DEGhent University Hospital · BEGZA Ziekenhuizen Campus Sint-Augustinus · BEHartcentrum Hasselt · BEHoward Hughes Medical Institute · USKlinikum Leverkusen · DEKU Leuven · BEUniversity Hospital of Geneva · CHVrije Universiteit Brussel · BE

Funding

Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
NCATS NIH HHS UL1 TR000043
6 · The paper itself

Abstract

Varicella zoster virus (VZV) typically causes chickenpox upon primary infection. In rare cases, VZV can give rise to life-threatening disease in otherwise healthy people, but the immunological basis for this remains unexplained. We report 4 cases of acute severe VZV infection affecting the central nervous system or the lungs in unrelated, otherwise healthy children who are heterozygous for rare missense mutations in POLR3A (one patient), POLR3C (one patient), or both (two patients). POLR3A and POLR3C encode subunits of RNA polymerase III. Leukocytes from all 4 patients tested exhibited poor IFN induction in response to synthetic or VZV-derived DNA. Moreover, leukocytes from 3 of the patients displayed defective IFN production upon VZV infection and reduced control of VZV replication. These phenotypes were rescued by transduction with relevant WT alleles. This work demonstrates that monogenic or digenic POLR3A and POLR3C deficiencies confer increased susceptibility to severe VZV disease in otherwise healthy children, providing evidence for an essential role of a DNA sensor in human immunity.

Indexed as

MutationAllelesAnimalsChickenpoxChildDNA Mutational AnalysisGene Expression Regulation, EnzymologicHEK293 CellsHerpesvirus 3, HumanHerpes ZosterHeterozygoteHumansLeukocytesMiceMutation, MissensePhenotypeRNA Polymerase III

Identifiers

PMID28783042
PMCPMC5669568
OpenAlexW2743446593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.